06 Nov MHC class I- and II-deficient humanized mice are suitable tools to test the long-term antitumor efficacy of immune checkpoint inhibitors and T-cell engagers

ID: 03344

Authors: Eguren-Santamaria, Iñaki (1); Fernández de Piérola, Eva (1); Camps, Gracián (1); Martín-Muñoz, Paula (1); Campos, María (2); Cuculescu, Doina (3); Aguilera-Buenosvinos, Inmaculada (4); Rodríguez-López, Inmaculada (1); Salido-Vallejo, Rafael (3); Alexandru, Raluca (3); de Andrea, Carlos (3); Álvarez-Gigli, Laura (3); Berraondo, Pedro (1); Melero, Ignacio (1); F. Sanmamed, Miguel (1)

Topic: INMUNOTHERAPY